Steven Muntean Corsello

Dana-Farber Cancer Inst

$1,032,695

Attributed

$1,032,695

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $206.5K · FY2018–22

$250K$187.5K$125K$62.5K$0

'18

'19

'20

'21

'22

Funding mix

By agency

NIH$1,032,695 · 1

By mechanism

K08$1,032,695 · 1

Top collaborators

No co-investigators on record.

Most similar at Dana-Farber Cancer Inst

Same institution · by research overlap

Others in their field

Other Emerging Leaders on “Advisory Committees”

Claudia Valmonte · The Emmes Company, Llc$37,865,589
James Lu · Helix$12,461,593
Hemali Phatnani · New York University School Of Medicine$12,067,974
Patrick A Flume · Medical University Of South Carolina$11,656,627
Sonia Savelli · University Of Washington$11,147,222
Rajni Samavedam · Booz Allen Hamilton$9,935,296

Research focus

Advisory CommitteesAffectAttentionBaseBassBeta CateninBinding ProteinsBiologyCancer BiologyCancer CellCancer Cell LineCancer EtiologyCancer GenomicsCancer TherapyCareerCaringCasein KinaseCasein Kinase ICell LineCessation Of LifeChemotherapy-Oncologic ProcedureClinical TranslationColon Cancer Cell LineAdvanced Malignant Neoplasm

Grant awards (6)

Targeting casein kinase 1-alpha for cancer therapy$206,539

K08 · FY2022 · CA · contact PI

Targeting casein kinase 1-alpha for cancer therapy$130,475

K08 · FY2021 · CA · contact PI

Targeting casein kinase 1-alpha for cancer therapy$76,064

K08 · FY2021 · CA · contact PI

Targeting casein kinase 1-alpha for cancer therapy$206,539

K08 · FY2020 · CA · contact PI

Targeting casein kinase 1-alpha for cancer therapy$206,539

K08 · FY2019 · CA · contact PI

Targeting casein kinase 1-alpha for cancer therapy$206,539

K08 · FY2018 · CA · contact PI